Virbac

Equities

VIRP

FR0000031577

Market Closed - Euronext Paris Other stock markets 11:35:09 2025-06-16 am EDT			5-day change	1st Jan Change
315.00 ^EUR	-0.94%		-3.37%	-0.47%

Apr. 16	VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway
Apr. 16	VIRBAC : Stifel still buying after Q1 results	CF

Virbac SA, 2024 Earnings Call, Mar 14, 2025

Published on 03/14/2025 at 09:15

Presenter Speech
Sandrine Brunel (Executives)

Good afternoon to all, and welcome to the Virbac 2024 Annual Results Webcast. We are very pleased to have you join us. Today's call is hosted by myself.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Virbac

VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway	Apr. 16
VIRBAC : Stifel still buying after Q1 results	Apr. 16	CF
French and Benelux stocks-Factors to watch	Apr. 16	RE
Virbac: Q1 sales up 8.5%	Apr. 15	CF
Virbac Q1 Revenue EUR 375.2 Million	Apr. 15	RE
Virbac Q1 2025 Revenue EUR 375.2 Mln	Apr. 15	RE
Virbac: surrounded on the back of a broker upgrade	Mar. 17	CF
VIRBAC : Oddo BHF remains 'neutral', confirms its target	Mar. 17	CF
VIRBAC : 2024 profitability somewhat exceeded expectations; stock re-rating underway	Mar. 17
VIRBAC : Stifel raises its recommendation	Mar. 17	CF
Virbac SA Seeks Acquisitions	Mar. 14	CI
Virbac SA, 2024 Earnings Call, Mar 14, 2025	Mar. 14
French and Benelux stocks-Factors to watch	Mar. 14	RE
Virbac: 20% increase in consolidated net income by 2024	Mar. 13	CF
Virbac SA Provides Financial Guidance for the Fiscal 2025	Mar. 13	CI
Virbac SA Reports Earnings Results for the Full Year Ended December 31, 2024	Mar. 12	CI
VIRBAC : 2024 top-line goals met; uninspiring 2025 outlook could be raised later	Jan. 17
Oddo BHF Downgrades Virbac to Neutral, Cuts PT	Jan. 17	MT
Virbac forecasts sales growth of 4 to 6% in 2025	Jan. 16	RE
Virbac SA Provides Revenue Guidance for the Year 2025	Jan. 16	CI
Virbac SA Reports Non-Audited Consolidated Revenue Results for the Fourth Quarter and Full Year Ended December 2024	Jan. 16	CI
A poor 2024 increases the odds of a brighter 2025	Jan. 02
Virbac SA's Equity Buyback announced on December 19, 2024 has expired.	Dec. 18	CI
Virbac Buys Turkish Animal Health Product Distributor Mopsan	Dec. 03	MT
Virbac SA acquired Mopsan Veteriner Urunleri A.S.	Dec. 02	CI